BioCardia, Inc. 8-K

What Happened BioCardia, Inc. filed a Form 8-K on June 8, 2026, disclosing that the company sold 3,509,604 shares of its common stock on June 5, 2026 under its “at-the-market” (ATM) offering agreement with H.C. Wainwright & Co. The shares were sold at an average price of $1.279 per share. A press release announcing the sale was attached to the 8-K as Exhibit 99.1.

Key Details

• Shares sold: 3,509,604 on June 5, 2026.
• Average sale price: $1.279 per share.
• Sales channel: pursuant to the company’s ATM offering agreement with H.C. Wainwright & Co.
• Implied gross proceeds: approximately $4.49 million (3,509,604 × $1.279), based on the reported average price.

Why It Matters This 8-K reports a capital-raising transaction that increases BioCardia’s cash on hand without a single large placement; ATM programs let the company sell shares into the market over time. For investors, the sale is material because it increases the number of shares outstanding (dilution) and reflects the company’s use of equity markets to raise funds. The filing is a routine disclosure of the transaction; the press release attached provides the company’s public announcement of the sale.